Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After Adalimumab Therapy

NCT01237262 is registered in ClinicalTrials.gov with University of Padova as lead sponsor.

NCT NCT01237262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01237262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After Adalimumab Therapy
Lead sponsor
University of Padova
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2010
Completion date
Not reported
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

absolute number, density of immune infiltrate and dendritic cells and inflammatory cytokines expression pattern., moderate to severe psoriasis.